ROCKET AF: A clinical Research Opportunity for People with an Irregular Heart Rhythm called Atrial Fibrillation. Atrial fibrillation (Afib) and risk of stroke—the serious side to having a heart that flutters...
Find out now if you can take part in the ROCKET AF Study
Click the button below to answer a short series of questions to help determine whether you pre-qualify to participate in the ROCKET AF Study.
You are under no obligation to participate, and all the information you submit will be held in confidence.
Learn more about your privacy.
What is Atrial fibrillation?
Atrial fibrillation (Afib) is when the heart beats irregularly and more rapidly than normal, also known as arrhythmia. Afib is the most common type of arrhythmia and can increase the risk of blood clots that cause stroke. A clinical research study is evaluating a new investigational medication designed to reduce the risk of blood clot formation that can lead to stroke.
People with Afib and at risk of blood clot formation are usually treated with blood thinners; one of the most frequently prescribed is warfarin (Coumadin®). While warfarin is effective at reducing the risk of blood clot formation, researchers are trying to develop more convenient treatments. A study called ROCKET AF is now underway to evaluate a new investigational medication and is looking for volunteers— could you take part?